Antibody data
- Antibody Data
- Antigen structure
- References [13]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 9101 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#9101, RRID:AB_331646
- Product name
- Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) Antibody
- Antibody type
- Polyclonal
- Reactivity
- Human, Mouse, Rat, Bovine, Drosophila, Hamster, Porcine, Simian, Other
- Host
- Rabbit
- Storage
- -20°C
Submitted references SRC signaling is crucial in the growth of synovial sarcoma cells.
Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα.
Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases.
Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling.
Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.
Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines.
PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects.
Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.
Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells.
Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors.
Analysis of the transcriptional program induced by Raf in epithelial cells.
Phosphorylation and regulation of Raf by Akt (protein kinase B).
Michels S, Trautmann M, Sievers E, Kindler D, Huss S, Renner M, Friedrichs N, Kirfel J, Steiner S, Endl E, Wurst P, Heukamp L, Penzel R, Larsson O, Kawai A, Tanaka S, Sonobe H, Schirmacher P, Mechtersheimer G, Wardelmann E, Büttner R, Hartmann W
Cancer research 2013 Apr 15;73(8):2518-28
Cancer research 2013 Apr 15;73(8):2518-28
Targeting CDK1 promotes FLT3-activated acute myeloid leukemia differentiation through C/EBPα.
Radomska HS, Alberich-Jordà M, Will B, Gonzalez D, Delwel R, Tenen DG
The Journal of clinical investigation 2012 Aug;122(8):2955-66
The Journal of clinical investigation 2012 Aug;122(8):2955-66
Akt-RSK-S6 kinase signaling networks activated by oncogenic receptor tyrosine kinases.
Moritz A, Li Y, Guo A, Villén J, Wang Y, MacNeill J, Kornhauser J, Sprott K, Zhou J, Possemato A, Ren JM, Hornbeck P, Cantley LC, Gygi SP, Rush J, Comb MJ
Science signaling 2010 Aug 24;3(136):ra64
Science signaling 2010 Aug 24;3(136):ra64
Activation of dorsal horn microglia contributes to diabetes-induced tactile allodynia via extracellular signal-regulated protein kinase signaling.
Tsuda M, Ueno H, Kataoka A, Tozaki-Saitoh H, Inoue K
Glia 2008 Mar;56(4):378-86
Glia 2008 Mar;56(4):378-86
Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2.
Kawagoe T, Sato S, Matsushita K, Kato H, Matsui K, Kumagai Y, Saitoh T, Kawai T, Takeuchi O, Akira S
Nature immunology 2008 Jun;9(6):684-91
Nature immunology 2008 Jun;9(6):684-91
Hepatitis C virus nonstructural protein 5A modulates the toll-like receptor-MyD88-dependent signaling pathway in macrophage cell lines.
Abe T, Kaname Y, Hamamoto I, Tsuda Y, Wen X, Taguwa S, Moriishi K, Takeuchi O, Kawai T, Kanto T, Hayashi N, Akira S, Matsuura Y
Journal of virology 2007 Sep;81(17):8953-66
Journal of virology 2007 Sep;81(17):8953-66
PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects.
Patrucco E, Notte A, Barberis L, Selvetella G, Maffei A, Brancaccio M, Marengo S, Russo G, Azzolino O, Rybalkin SD, Silengo L, Altruda F, Wetzker R, Wymann MP, Lembo G, Hirsch E
Cell 2004 Aug 6;118(3):375-87
Cell 2004 Aug 6;118(3):375-87
Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.
Zhang YW, Su Y, Volpert OV, Vande Woude GF
Proceedings of the National Academy of Sciences of the United States of America 2003 Oct 28;100(22):12718-23
Proceedings of the National Academy of Sciences of the United States of America 2003 Oct 28;100(22):12718-23
Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
Yu C, Krystal G, Varticovksi L, McKinstry R, Rahmani M, Dent P, Grant S
Cancer research 2002 Jan 1;62(1):188-99
Cancer research 2002 Jan 1;62(1):188-99
Pharmacological inhibitors of the mitogen-activated protein kinase (MAPK) kinase/MAPK cascade interact synergistically with UCN-01 to induce mitochondrial dysfunction and apoptosis in human leukemia cells.
Dai Y, Yu C, Singh V, Tang L, Wang Z, McInistry R, Dent P, Grant S
Cancer research 2001 Jul 1;61(13):5106-15
Cancer research 2001 Jul 1;61(13):5106-15
Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors.
Chow S, Patel H, Hedley DW
Cytometry 2001 Apr 15;46(2):72-8
Cytometry 2001 Apr 15;46(2):72-8
Analysis of the transcriptional program induced by Raf in epithelial cells.
Schulze A, Lehmann K, Jefferies HB, McMahon M, Downward J
Genes & development 2001 Apr 15;15(8):981-94
Genes & development 2001 Apr 15;15(8):981-94
Phosphorylation and regulation of Raf by Akt (protein kinase B).
Zimmermann S, Moelling K
Science (New York, N.Y.) 1999 Nov 26;286(5445):1741-4
Science (New York, N.Y.) 1999 Nov 26;286(5445):1741-4
No comments: Submit comment
No validations: Submit validation data